Literature DB >> 22296771

From stem cells to cancer stem cells: HIF takes the stage.

Kyoung Eun Lee1, M Celeste Simon.   

Abstract

Hypoxia, a condition of insufficient oxygen availability, occurs during normal development as well as tumorigenesis. Cellular responses to hypoxia are primarily mediated by hypoxia-inducible factors (HIFs). Recent studies have revealed that dormant hematopoietic stem cells (HSCs) reside within hypoxic regions of the bone marrow and that HIF is a critical player in HSC homeostasis. The functional significance of HIF in maintaining stemness also applies to cancer stem cells in hematological malignancies. These findings indicate that better understanding of the mechanisms underlying HIF functions in stem cells should permit the development of new therapies for tissue regeneration and cancer.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296771     DOI: 10.1016/j.ceb.2012.01.005

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  29 in total

1.  The TIP60 Complex Is a Conserved Coactivator of HIF1A.

Authors:  Joel I Perez-Perri; Veronica L Dengler; K Audrey Audetat; Ahwan Pandey; Elizabeth A Bonner; Marjeta Urh; Jacqui Mendez; Danette L Daniels; Pablo Wappner; Matthew D Galbraith; Joaquín M Espinosa
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

Review 2.  The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.

Authors:  Najah Albadari; Shanshan Deng; Wei Li
Journal:  Expert Opin Drug Discov       Date:  2019-05-09       Impact factor: 6.098

Review 3.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

Authors:  Rakesh K Jain
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

Review 4.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response.

Authors:  S R McKeown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

Review 5.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

6.  Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.

Authors:  P Sontakke; M Carretta; J Jaques; A Z Brouwers-Vos; L Lubbers-Aalders; H Yuan; J D de Bruijn; A C M Martens; E Vellenga; R W J Groen; J J Schuringa
Journal:  Leukemia       Date:  2016-04-29       Impact factor: 11.528

7.  SOD2 and the Mitochondrial UPR: Partners Regulating Cellular Phenotypic Transitions.

Authors:  Chenxia He; Peter C Hart; Doris Germain; Marcelo G Bonini
Journal:  Trends Biochem Sci       Date:  2016-05-11       Impact factor: 13.807

8.  MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.

Authors:  Kyung-Min Lee; Jennifer M Giltnane; Justin M Balko; Luis J Schwarz; Angel L Guerrero-Zotano; Katherine E Hutchinson; Mellissa J Nixon; Mónica V Estrada; Violeta Sánchez; Melinda E Sanders; Taekyu Lee; Henry Gómez; Ana Lluch; J Alejandro Pérez-Fidalgo; Melissa Magdalene Wolf; Gabriela Andrejeva; Jeffrey C Rathmell; Stephen W Fesik; Carlos L Arteaga
Journal:  Cell Metab       Date:  2017-10-03       Impact factor: 27.287

9.  HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.

Authors:  Roberta Valsecchi; Nadia Coltella; Daniela Belloni; Manfredi Ponente; Elisa Ten Hacken; Cristina Scielzo; Lydia Scarfò; Maria Teresa Sabrina Bertilaccio; Paola Brambilla; Elisa Lenti; Filippo Martinelli Boneschi; Andrea Brendolan; Elisabetta Ferrero; Marina Ferrarini; Paolo Ghia; Giovanni Tonon; Maurilio Ponzoni; Federico Caligaris-Cappio; Rosa Bernardi
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

Review 10.  Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia?

Authors:  M Belmonte; C Hoofd; A P Weng; V Giambra
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.